Cross Shawn sold PCRX
November 10, 2025 · Form 4 insider transaction
Cross Shawn sold 12,060 shares of Pacira BioSciences, Inc. at $22.09 per share, a transaction worth $266.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,060
Price
$22.09
Total value
$266.4K
InsiderCross Shawn
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 10, 2025
Filing dateNovember 13, 2025
Shares owned after56,250
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.